Monte Rosa Therapeutics, Inc. (NASDAQ:GLUE) Short Interest Update
Monte Rosa Therapeutics, Inc. (NASDAQ:GLUE – Get Free Report) was the recipient of a significant decline in short interest in January. As of January 15th, there was short interest totaling 5,554,802 shares, a decline of 34.3% from the December 31st total of 8,454,052 shares. Based on an average daily volume of 4,043,321 shares, the days-to-cover […]
1 Feb 00:42 · The Markets Daily